Jonathan McNeill, Chief Business Officer at Dyne Therapeutics, Inc. (DYN), sold 5,053 shares at $28.20 ($143K) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Scheduled sale ($143k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.20 | 2,279 | $64K | 45.0% |
| 2 | $28.20 | 2,279 | $64K | 45.0% |
| 3 | $28.59 | 495 | $14K | 9.9% |
| Total | $28.24 avg | 5,053 | $143K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $122K | — | Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-03-13 | $5.2M | — | Filing → |